Madame Bioscience PCL (BKK:MADAME)
Thailand · Delayed Price · Currency is THB 0.8300
0.00 (0.00%)
At close: Aug 10, 2026
Madame Bioscience PCL Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 670 | 565 | 755 | 1,138 | 2,061 | 2,607 | |
Market Cap Growth | -2.38% | -25.15% | -33.63% | -44.78% | -20.94% | 45.01% |
Enterprise Value | 796 | 864 | 1,447 | 1,838 | 2,493 | 2,720 |
Last Close Price | 0.83 | 0.70 | 1.10 | 1.85 | 3.35 | 6.15 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 12.36 | - | - | - | - |
PS Ratio | 0.44 | 0.38 | 0.36 | 0.49 | 0.93 | 1.40 |
PB Ratio | 0.82 | 0.71 | 1.39 | 1.46 | 1.73 | 2.94 |
P/TBV Ratio | 1.96 | 1.78 | 3.84 | 2.65 | 3.21 | 3.14 |
P/FCF Ratio | - | - | 3.57 | 35.16 | - | - |
P/OCF Ratio | 543.17 | 14.24 | 3.33 | 15.81 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.52 | 0.58 | 0.68 | 0.80 | 1.12 | 1.46 |
EV/EBITDA Ratio | - | - | 13.04 | - | - | - |
EV/EBIT Ratio | - | - | 34.19 | - | - | - |
EV/FCF Ratio | - | - | 6.84 | 56.78 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.27 | 0.31 | 1.13 | 1.06 | 0.77 | 0.37 |
Debt / EBITDA Ratio | - | - | 4.61 | - | - | - |
Debt / FCF Ratio | - | - | 2.90 | 25.32 | - | - |
Net Debt / Equity Ratio | 0.10 | 0.06 | 0.98 | 1.01 | 0.56 | 0.31 |
Net Debt / EBITDA Ratio | -0.24 | -0.43 | 4.81 | -9.60 | -2.16 | -7.66 |
Net Debt / FCF Ratio | -1.96 | -28.19 | 2.52 | 24.24 | -2.17 | -0.89 |
Asset Turnover | 1.03 | 1.01 | 1.16 | 1.02 | 1.10 | 1.21 |
Inventory Turnover | 17.68 | 12.23 | 9.29 | 7.74 | 6.68 | 5.14 |
Quick Ratio | 1.09 | 1.02 | 0.52 | 0.40 | 0.97 | 0.73 |
Current Ratio | 1.41 | 1.22 | 0.71 | 0.68 | 1.52 | 1.54 |
Return on Equity (ROE) | -20.40% | 6.94% | -49.78% | -41.90% | -42.18% | -17.59% |
Return on Assets (ROA) | -16.86% | -7.89% | 1.45% | -4.62% | -11.92% | -4.47% |
Return on Invested Capital (ROIC) | -46.11% | -17.95% | 3.21% | -9.72% | -25.55% | -9.73% |
Return on Capital Employed (ROCE) | -39.60% | -18.70% | 5.30% | -15.10% | -20.50% | -10.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -23.96% | 8.09% | -43.90% | -35.65% | -20.49% | -5.85% |
FCF Yield | -6.19% | -0.31% | 28.01% | 2.84% | -14.92% | -11.69% |
Buyback Yield / Dilution | -15.52% | -24.47% | -0.93% | -2.57% | -50.07% | -5.07% |